| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.95▲ | 9.87▲ | 9.87▲ | 9.80▲ | 9.67▲ |
| MA10 | 9.91▲ | 9.85▲ | 9.79▲ | 9.69▲ | 8.93▲ |
| MA20 | 9.88▲ | 9.78▲ | 9.68▲ | 9.60▲ | 8.18▲ |
| MA50 | 9.85▲ | 9.67▲ | 9.73▲ | 8.77▲ | 11.40▼ |
| MA100 | 9.80▲ | 9.72▲ | 9.61▲ | 8.12▲ | 22.14▼ |
| MA200 | 9.68▲ | 9.60▲ | 9.49▲ | 9.49▲ | 30.53▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | 0.015▲ | 0.040▲ | -0.033▼ | 0.628▲ |
| RSI | 66.107▲ | 65.858▲ | 63.790▲ | 60.982▲ | 54.367▲ |
| STOCH | 72.276 | 57.379 | 75.370 | 68.060 | 84.127▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -14.251▲ | -6.733▲ |
| CCI | 153.829▲ | 162.621▲ | 104.502▲ | 91.974 | 94.136 |
|
Wednesday, November 05, 2025 11:15 AM
Arvinas Inc (ARVN) showcases promising clinical progress and strategic partnerships, despite facing revenue declines and operational downsizing.
|
|
Wednesday, November 05, 2025 04:12 AM
Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the third quarter ended ...
|
|
Tuesday, November 04, 2025 05:39 AM
This article first appeared on GuruFocus. Arvinas Inc (NASDAQ:ARVN) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $23.60 million, and the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/25 | 9.705 | 10.02 | 9.64 | 10.01 | 1,502,711 |
| 05/11/25 | 9.43 | 9.79 | 9.27 | 9.57 | 2,287,931 |
| 04/11/25 | 9.52 | 9.72 | 9.505 | 9.54 | 2,239,643 |
| 03/11/25 | 10.14 | 10.14 | 9.54 | 9.72 | 1,978,039 |
| 31/10/25 | 9.99 | 10.14 | 9.80 | 10.14 | 2,228,972 |
| 30/10/25 | 9.88 | 10.1762 | 9.71 | 9.93 | 2,758,745 |
| 29/10/25 | 9.41 | 9.635 | 9.40 | 9.59 | 2,734,740 |
| 28/10/25 | 9.57 | 9.62 | 9.39 | 9.50 | 2,241,119 |
| 27/10/25 | 9.30 | 9.68 | 9.25 | 9.65 | 1,763,102 |
| 24/10/25 | 9.25 | 9.55 | 9.09 | 9.21 | 3,459,584 |
|
|
||||
|
|
||||
|
|